NCT02864472View on ClinicalTrials.gov

Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading Dose

PHASE4UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

January 31, 2019

Conditions
Age-related Macular Degeneration
Interventions
PROCEDURE

PDT

PDT and ranibizumab

DRUG

Ranibizumab

Ranibizumab

DRUG

ranibizumab PRN

ranibizumab PRN

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Seoul National University Hospital

OTHER